Scientific Advisory Board

Scott T. Aaronson, MD

Scott T. Aaronson, MD

Dr. Aaronson specializes in treatment-resistant affective disorders. He is a thought leader in the areas of biological psychiatry, diagnosis and the integration of somatic and psychological therapies. He is the principal investigator for multiple studies on the development of novel therapies for mood, anxiety and psychotic disorders. Dr. Aaronson is a valued speaker and educator and frequently lectures, regionally and […]
View Profile
P. Murali Doraiswamy, MD

P. Murali Doraiswamy, MD

Dr. Doraiswamy is a globally recognized expert and researcher focusing on intervention and treatment possibilities for Alzheimer’s and other memory disorders. He has served as an advisor to leading government agencies and pharmaceutical companies, and published more than 200 scientific articles. He is the co-author of The Alzheimer’s Action Plan, as well as the e-book Living Well After a Diagnosis […]
View Profile
Maurizio Fava, MD

Maurizio Fava, MD

Dr. Fava has been Principal Investigator of more than 40 NIMH and industry-supported clinical trials in unipolar depression. His clinical and consulting practice specializes in treatment resistant depression and he consults extensively with colleagues on management of this condition. Having co-authored more than 450 original articles published in medical journals with international circulation, he has also edited six books and […]
View Profile
Anil Malhotra, MD

Anil Malhotra, MD

Dr. Malhotra is the Director of Psychiatry Research at the Zucker Hillside Hospital in Glen Oaks, NY, Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine (AECOM) in the Bronx, NY, and an Investigator at the Feinstein institute for Medical Research in Manhasset, NY. Dr. Malhotra’s research group currently focuses on identifying the biological underpinnings of […]
View Profile
Roy H. Perlis, MD, MSc

Roy H. Perlis, MD, MSc

Dr. Perlis’ clinical work and research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder. He is the author of more than 100 peer-reviewed research publications as well as numerous book chapters and reviews. His current research efforts include identifying predictors of treatment response and identifying and studying novel treatments for mood disorders. […]
View Profile
Stephen M. Stahl, MD, PhD

Stephen M. Stahl, MD, PhD

An author of over 425 articles and more than 1500 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has edited five books and written 25 more, including the best-selling textbook Stahl’s Essential Psychopharmacology, now in its third edition, and the best-selling clinical manual, Essential Psychopharmacology […]
View Profile
Rudolph E. Tanzi, PhD

Rudolph E. Tanzi, PhD

Dr. Tanzi is the director of the Genetics and Aging Research Unit at the Massachusetts General Institute for Neurodegenerative Disease in Boston. He is also a professor of neurology and holder of the Joseph P. and Rose F. Kennedy Endowed Chair in Neurology and Mental Retardation at Harvard University. Dr. Tanzi is a widely respected researcher focusing on the molecular […]
View Profile